Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Jirkowic T, Graham CJ, Grant T. A trauma-informed parenting intervention model for mothers parenting young children during residential treatment for substance use disorder. Occupational Therapy in Mental Health 2023;39(2):156-183. [doi:10.1080/0164212X.2022.2089315]
  2. Boyle HK, Singh S, Lopez G, Carey KB, Jackson KM, Merrill JE. A qualitative examination of the decision-making process of simultaneous alcohol and cannabis use: Intentions and willingness. Alcohol: Clinical & Experimental Research 2023;47(1):168-179. [doi: 10.1111/acer.14982] PMID: 36480451 PMCID: PMC10275144
  3. McClure EA, Hamilton L, Schauer GL, Matson TE, Lapham GT. Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access. Addictive Behaviors 2023;140:107621. [doi: 10.1016/j.addbeh.2023.107621] PMID: 36706676 PMCID: PMC10854219
  4. Owens M, Borges A, McGrath J, Stern MF. The Status of Medications for Opioid Use Disorder (MOUD) Provision in Washington State Jails, 2021. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, May 2023
  5. Floyd AS, Silcox J, Cousin E, Irwin AN, Gray M, Bolivar D, Bratberg J, Arnold J, Al-jammali Z, Hansen RN, Hartung DM, Green TC. Readiness of community pharmacies to implement an opioid safety intervention. Journal of the American Pharmacists Association 2023:63(1):275-283.e1. [doi: 10.1016/j.japh.2022.10.031] PMID: 36496310 PMCID: PMC9870924
  6. Gray M, Shin SS, Silcox J, Flores D, Bolivar D, Irwin AN, Floyd AS, Bratberg J, Boggis JS, Hartung DM, Green TC. “Like it was just everyday business”: A qualitative study of pharmacy-based naloxone and syringe customer experience. Journal of the American Pharmacists Association 2023;63(3):838-846. [doi: 10.1016/j.japh.2023.01.013] PMID: 36872182 PMCID: PMC10198806
  7. Winstead T, Newman A, Maroon E, Banta-Green C. Unmet Needs, Complex Motivations, and Care for People Using Fentanyl in Washington State: A Qualitative Study. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2023
  8. Chaple MJ, Kunins HV, Nass MD, Benjamin AC, Viel CR, Bertone P, Marker L, Warren P, Hartzler B. Exploring the impact of external facilitation using evidence-based implementation strategies for increasing motivational interviewing capacity among outpatient substance use treatment providers. Journal of Behavioral Health Services & Research 2023;51:185-202. [doi: 10.1007/s11414-023-09871-2] PMID: 38030934
  9. Kingston S. Overview and Perspectives of Syringe Services Programs in Washington State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, February 2023
  10. Hartzler B. Is it time to broaden community dissemination of cognitive-behavioral therapy for substance use disorders: Charting pathways to ascend the remaining mountainside [commentary]. Clinical Psychology: Science and Practice 2023;30(2):147-149. [doi: 10.1037/cps0000138]
  11. Peavy KM, Adwell A, Owens MD, Banta-Green CJ. Perspectives on medication treatment for opioid use disorder in adolescents: Results from a provider learning series. Substance Use & Misuse 2023;58(1):160-162. [doi: 10.1080/10826084.2022.2136493] PMID: 36371698
  12. Banta-Green C, Duncan M. Treatment Medications for Fentanyl Use Disorder: Prescriber Practices and Support Needs in WA State. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, September 2023
  13. Fockele CE, Morse SC, van Draanen J, Leyde S, Banta-Green C, Huynh LN, Zatzick A, Whiteside LK. “That line that just kept moving”: Motivations and experiences of people who use methamphetamine. West J Emerg Med 2023;24(2):218-227. [doi: 10.5811/westjem.2022.12.58396] PMID: 36976607 PMCID: PMC10047723
  14. Carlini B, Garrett S, Kellum L, Nims L. Cannabis Research Report, 2021-2023. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, August 2023
  15. Kingston S, Biamont B, Banta-Green C. Community Drug Checking Network. The Use and Impact of Community Drug Checking Services. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, November 2023
  16. Irwin AN, Bratberg J, Al-Jammali Z, Arnold J, Gray M, Floyd AS, Boliver D, Hansen R, Hartun DM, Green TC. Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician. Journal of the American Pharmacists Association 2023;63(1):284-294.e1. [doi: 10.1016/j.japh.2022.12.001] PMID: 36567216 PMCID: PMC9933140
  17. Hall W, Leung J, Carlini BH. Do not let the ideal be the enemy of good enough regulation [commentary]. Addiction 2023;118(6):1009-1010. [doi: 10.1111/add.16201]
  18. Owens MD, Banta-Green CJ, Newman A, Marren R, Takushi R. Insights into a recovery community center model: Results from qualitative interviews with staff and member facilitators from Recovery Cafe in Seattle, Washington. Alcoholism Treatment Quarterly 2023; 41(1):62-75. [doi: 10.1080/07347324.2022.2088323]
  19. Stoner SA, Graham JC, Grant TM. Evaluating outcomes of a three-year case management program for mothers with prenatal substance use according to race/ethnicity, Washington State, 2006–2017. BMC Public Health 2023;23:1832. [doi: 10.1186/s12889-023-16670-z] PMID: 37730578 PMCID: PMC10512570
  20. Boyle HK, Singh S, Lopez G, Jackson KM, Carey KB, Merrill JE. Insights into the context of simultaneous alcohol and cannabis use among young adults. Experimental and Clinical Psychopharmacology 2023;31(3):662-673. [doi: 10.1037/pha0000607] PMID: 36174141 PMCID: PMC10201978